Oncology Medical News about MBD

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Surgical management of metastatic bone disease
Journal of Bone and Joint Surgery, 06/05/09

Bickels J et al. - In a review of the surgical management of metastatic bone disease, it was concluded that detailed preoperative evaluation is required to assess the local extent of bone destruction and soft-tissue involvement, involvement of other skeletal sites, and overall medical and oncological status.

Methods

Metastatic bone disease is a major contributor to the deterioration of quality of life of pts with cancer.
It causes pain, impending and actual pathological fractures, and loss of function and may be associated with considerable metabolic alterations.

Results

Operative treatment may be required for an impending or existing fracture and intractable pain.
Goals of surgery are to provide local tumor control and allow immediate weight-bearing and function.
Radiation therapy is often indicated postoperatively.

<< Previous
Increased expression of both insulin receptor substrates 1 and 2...

Next >>
Sentinel lymph node sampling in gynaecological cancers:...

Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD)
Pediatric Nephrology, 11/11/09 Relevance Score: 87%

Methylene Blue Dye, an Accurate Dye for Sentinel Lymph Node Identification in Early Breast Cancer
Anticancer Research, 11/11/09 Relevance Score: 87%

Multiple symptoms of higher brain dysfunction caused by Marchiafava–Bignami disease in a patient with dermatomyositis
Rheumatology International, 11/16/09 Relevance Score: 80%